封面
市场调查报告书
商品编码
1746933

日本辅助生殖技术市场报告(按产品、类型(体外受精、人工授精)、最终用途和地区)2025-2033

Japan Assisted Reproductive Technology Market Report by Product, Type (In-Vitro Fertilization, Artificial Insemination), End Use, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年,日本辅助生殖技术市场规模达35.247亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到63.29亿美元,2025-2033年期间的复合年增长率(CAGR)为6.7%。日本不孕症盛行率的上升、政府推出的支持措施、辅助生殖技术(ART)的近期技术进步,以及社会对不孕症治疗的认知度和接受度的提高,是推动市场发展的一些关键因素。

辅助生殖技术 (ART) 是指主要用于治疗不孕症的医疗程序。它涵盖多种方法,例如体外受精 (IVF)、卵胞浆内单一精子注射 (ICSI)、配子或胚胎冷冻保存以及生育药物治疗。 ART 具有许多优势,例如能够绕过受精过程中的生理障碍、提高配子品质或维持生育能力。它融合了医学专业知识、先进的实验室、法律框架和伦理管理。 ART 被不孕夫妇、单身人士以及渴望成为父母的男女同性恋群体广泛使用。此外,它还可用于预防遗传性疾病、平衡家庭关係、促进代孕以及癌症患者的生育能力保存。 ART 可以提高受孕几率、控制受孕时机、筛检遗传疾病,并增进人们对自身生育能力的了解。除此之外,它还提供了许多优势,例如多次怀孕的选择以及允许同性伴侣或单亲父母怀孕。

日本辅助生殖科技市场趋势:

由于生活方式的改变和老龄人口的增加,日本不孕症的盛行率不断上升,这是推动市场成长的关键因素之一。此外,政府推出的支持措施,例如补贴辅助生殖技术(ART)以鼓励夫妻寻求治疗,也正在推动市场成长。此外,辅助生殖技术(ART)的最新技术进步提高了成功率,从而促进了其应用,也催化了市场成长。此外,社会对不孕症治疗的认识和接受度不断提高,也促进了市场成长。此外,监管框架的持续改进为潜在患者提供了安全保障,也推动了市场成长。此外,日本可支配收入的增加,使更多人能够负担得起通常昂贵的辅助生殖技术(ART)等治疗,这也促进了市场成长。此外,主要参与者不断增加对研发和创新的投资,以开发有效的不孕症治疗方案,也对市场成长产生了正面影响。此外,日本和国际生育诊所之间日益增多的合作,旨在扩大最佳实践和先进治疗手段的可及性,也支持了市场成长。同时,日本文化中日益增长的社会压力和家庭创造慾望正在推动市场成长。此外,生育旅游的兴起,使人们能够前往日本享受高品质的辅助生殖技术 (ART) 服务,也刺激了市场成长。此外,辅助生殖技术服务扩展到更广泛的人群,包括老年女性和单身人士,开闢了新的细分市场,也加速了市场的成长。此外,基因筛检技术的最新进展使辅助生殖技术更加安全可靠,这也正在加强全国市场的成长。

日本辅助生殖技术市场区隔:

产品洞察:

  • 乐器
    • 精子分离系统
    • 低温系统
    • 孵化器
    • 影像系统
    • 卵子抽吸泵
    • 内阁
    • 微操作器
    • 雷射系统
    • 其他的
  • 配件及抛弃式用品
  • 试剂和培养基
    • 冷冻保存培养基
    • 精液处理培养基
    • 卵子处理培养基
    • 胚胎培养基

类型洞察:

  • 体外受精(IVF)
    • 新鲜供体
    • 冷冻捐赠者
    • 新鲜非供体
    • 冷冻非捐赠者
  • 人工授精
    • 子宫腔内授精
    • 子宫颈内授精
    • 阴道内授精
    • 输卵管内授精

最终用途洞察:

  • 生育诊所和其他设施
  • 医院及其他

竞争格局:

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外,报告还提供了所有主要公司的详细资料。

本报告回答的关键问题:

  • 日本辅助生殖技术市场迄今表现如何?未来几年将如何表现?
  • COVID-19对日本辅助生殖技术市场有何影响?
  • 日本辅助生殖技术市场依产品划分是怎样的?
  • 日本辅助生殖技术市场按类型划分是怎样的?
  • 日本辅助生殖技术市场根据最终用途的分布如何?
  • 日本辅助生殖技术市场的价值链分为哪些阶段?
  • 日本辅助生殖技术的关键驱动因素和挑战是什么?
  • 日本辅助生殖技术市场的结构是怎么样的?主要参与者是谁?
  • 日本辅助生殖技术市场的竞争程度如何?

本报告回答的关键问题:

  • 日本辅助生殖技术市场迄今表现如何?未来几年将如何表现?
  • COVID-19对日本辅助生殖技术市场有何影响?
  • 日本辅助生殖技术市场依产品划分是怎样的?
  • 日本辅助生殖技术市场按类型划分是怎样的?
  • 日本辅助生殖技术市场根据最终用途的分布如何?
  • 日本辅助生殖技术市场的价值链分为哪些阶段?
  • 日本辅助生殖技术的关键驱动因素和挑战是什么?
  • 日本辅助生殖技术市场的结构是怎么样的?主要参与者是谁?
  • 日本辅助生殖技术市场的竞争程度如何?

目录

第一章:前言

第二章:范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章:执行摘要

第四章:日本辅助生殖科技市场 - 简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章:日本辅助生殖技术市场概况

  • 历史与当前市场趋势(2019-2024)
  • 市场预测(2025-2033)

第六章:日本辅助生殖技术市场-细分:依产品

  • 乐器
    • 概述
    • 市场区隔
      • 精子分离系统
      • 低温系统
      • 孵化器
      • 影像系统
      • 卵子抽吸泵
      • 内阁
      • 微操作器
      • 雷射系统
      • 其他的
  • 配件及抛弃式用品
    • 概述
  • 试剂和培养基
    • 概述
    • 市场区隔
      • 冷冻保存培养基
      • 精液处理培养基
      • 卵子处理培养基
      • 胚胎培养基

第七章:日本辅助生殖技术市场-细分:依类型

  • 体外受精(IVF)
    • 概述
    • 市场区隔
      • 新鲜供体
      • 冷冻捐赠者
      • 新鲜非供体
      • 冷冻非捐赠者
  • 人工授精
    • 概述
    • 市场区隔
      • 子宫腔内授精
      • 子宫颈内授精
      • 阴道内授精
      • 输卵管内授精

第 8 章:日本辅助生殖科技市场 - 分裂:最终用途别

  • 生育诊所和其他设施
    • 概述
  • 医院及其他
    • 概述

第九章:日本辅助生殖技术市场-竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第十章:关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章:日本辅助生殖技术市场-产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 12 章:附录

简介目录
Product Code: SR112025A19599

Japan assisted reproductive technology market size reached USD 3,524.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 6,329.0 Million by 2033, exhibiting a growth rate (CAGR) of 6.7% during 2025-2033. The increasing prevalence of infertility in Japan, introduction of supportive measures by the government, recent technological advancements in ART, and rising awareness and societal acceptance of infertility treatment represent some of the key factors driving the market.

Assisted reproductive technology (ART) refers to medical procedures used primarily to address infertility. It includes a variety of methodologies, such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, and fertility medication. ART possesses several features, like the ability to bypass physiological hurdles to fertilization, enhance gamete quality, or preserve fertility. It is comprised of medical expertise, sophisticated laboratories, legal frameworks, and ethical governance. ART is widely used by infertile couples, single individuals, and the lesbian and gay community desiring parenthood. It also finds applications in genetic disorder prevention, family balancing, surrogacy facilitation, and fertility preservation for cancer patients. ART offers a higher chance of conception, control over timing, the possibility of screening for genetic diseases, and increased knowledge about one's fertility. In addition to this, it provides several advantages, such as options for multiple pregnancy attempts and allowing same-sex couples or single parents to conceive.

Japan Assisted Reproductive Technology Market Trends:

The increasing prevalence of infertility in Japan due to lifestyle changes and the rising geriatric population represents one of the key factors propelling the market growth. Additionally, the introduction of supportive measures by the government, such as subsidizing ART procedures to encourage couples to seek treatment, is boosting the market growth. Besides this, recent technological advancements in ART that are enhancing success rates, thus boosting its adoption, are catalyzing the market growth. Furthermore, the rising awareness and social acceptance of infertility treatments are contributing to the market growth. In addition, the ongoing improvements in the regulatory framework, which provide safety assurances to potential patients, are driving the market growth. Apart from this, the increasing disposable incomes in Japan, allowing more individuals to afford often expensive treatments, such as ART, is bolstering the market growth. Moreover, the escalating investment in research and innovation by key players to develop effective treatment options for infertility is positively influencing the market growth. Along with this, the rising collaborations between Japanese and international fertility clinics to expand access to best practices and advanced treatments are supporting the market growth. In line with this, the increasing societal pressure and desire for family creation in Japan's culture is fueling the market growth. Additionally, the emergence of fertility tourism, allowing people to visit Japan for high-quality ART services, is stimulating the market growth. Furthermore, the extension of ART services to a broader demographic, including older women and single individuals, which is opening new segments, is accelerating the market growth. Besides this, recent advancements in genetic screening technologies that are making ART safer and more reliable are strengthening the market growth across the country.

Japan Assisted Reproductive Technology Market Segmentation:

Product Insights:

  • Instrument
    • Sperm Separation System
    • Cryosystem
    • Incubator
    • Imaging System
    • Ovum Aspiration Pump
    • Cabinet
    • Micromanipulator
    • Laser Systems
    • Others
  • Accessory and Disposable
  • Reagents and Media
    • Cryopreservation Media
    • Semen Processing Media
    • Ovum Processing Media
    • Embryo Culture Media

Type Insights:

  • In-Vitro Fertilization (IVF)
    • Fresh Donor
    • Frozen Donor
    • Fresh Non-Donor
    • Frozen Non-Donor
  • Artificial Insemination
    • Intrauterine Insemination
    • Intracervical Insemination
    • Intravaginal Insemination
    • Intratubal Insemination

End Use Insights:

  • Fertility Clinics and Other Facilities
  • Hospitals and Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan assisted reproductive technology market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan assisted reproductive technology market?
  • What is the breakup of the Japan assisted reproductive technology market on the basis of product?
  • What is the breakup of the Japan assisted reproductive technology market on the basis of type?
  • What is the breakup of the Japan assisted reproductive technology market on the basis of end use?
  • What are the various stages in the value chain of the Japan assisted reproductive technology market?
  • What are the key driving factors and challenges in the Japan assisted reproductive technology?
  • What is the structure of the Japan assisted reproductive technology market and who are the key players?
  • What is the degree of competition in the Japan assisted reproductive technology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Assisted Reproductive Technology Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Assisted Reproductive Technology Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Assisted Reproductive Technology Market - Breakup by Product

  • 6.1 Instrument
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Sperm Separation System
      • 6.1.3.2 Cryosystem
      • 6.1.3.3 Incubator
      • 6.1.3.4 Imaging System
      • 6.1.3.5 Ovum Aspiration Pump
      • 6.1.3.6 Cabinet
      • 6.1.3.7 Micromanipulator
      • 6.1.3.8 Laser Systems
      • 6.1.3.9 Others
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 Accessory and Disposable
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Reagents and Media
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Segmentation
      • 6.3.3.1 Cryopreservation Media
      • 6.3.3.2 Semen Processing Media
      • 6.3.3.3 Ovum Processing Media
      • 6.3.3.4 Embryo Culture Media
    • 6.3.4 Market Forecast (2025-2033)

7 Japan Assisted Reproductive Technology Market - Breakup by Type

  • 7.1 In-Vitro Fertilization (IVF)
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Segmentation
      • 7.1.3.1 Fresh Donor
      • 7.1.3.2 Frozen Donor
      • 7.1.3.3 Fresh Non-Donor
      • 7.1.3.4 Frozen Non-Donor
    • 7.1.4 Market Forecast (2025-2033)
  • 7.2 Artificial Insemination
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Intrauterine Insemination
      • 7.2.3.2 Intracervical Insemination
      • 7.2.3.3 Intravaginal Insemination
      • 7.2.3.4 Intratubal Insemination
    • 7.2.4 Market Forecast (2025-2033)

8 Japan Assisted Reproductive Technology Market - Breakup by End Use

  • 8.1 Fertility Clinics and Other Facilities
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Hospitals and Others
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan Assisted Reproductive Technology Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Assisted Reproductive Technology Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix